Orujyan et al., 2022 - Google Patents
Protective efficacy of BCG vaccine against Mycobacterium leprae and non-tuberculous mycobacterial infectionsOrujyan et al., 2022
View HTML- Document ID
- 5268629098162519863
- Author
- Orujyan D
- Narinyan W
- Rangarajan S
- Rangchaikul P
- Prasad C
- Saviola B
- Venketaraman V
- Publication year
- Publication venue
- Vaccines
External Links
Snippet
The genus mycobacterium includes several species that are known to cause infections in humans. The microorganisms are classified into tuberculous and non-tuberculous based on their morphological characteristics, defined by the dynamic relationship between the host …
- 229960004689 BCG Vaccine 0 title abstract description 45
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| To et al. | General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus | |
| Luce-Fedrow et al. | A review of scrub typhus (Orientia tsutsugamushi and related organisms): then, now, and tomorrow | |
| Ansari et al. | Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity | |
| Delghandi et al. | Mycobacteriosis and infections with non-tuberculous mycobacteria in aquatic organisms: A review | |
| Rayamajhee et al. | A systematic review of intracellular microorganisms within Acanthamoeba to understand potential impact for infection | |
| Wang et al. | Staphylococcus aureus extracellular vesicles: a story of toxicity and the stress of 2020 | |
| Silva et al. | Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer | |
| Orujyan et al. | Protective efficacy of BCG vaccine against Mycobacterium leprae and non-tuberculous mycobacterial infections | |
| Zeng et al. | Rapid and broad immune efficacy of a recombinant five-antigen vaccine against Staphylococcus aureus infection in animal models | |
| Nowlan et al. | Advancements in characterizing Tenacibaculum infections in Canada | |
| Choi et al. | Antigen-specific IFN-γ/IL-17-co-producing CD4+ T-cells are the determinants for protective efficacy of tuberculosis subunit vaccine | |
| Cleveland et al. | Borrelia miyamotoi: a comprehensive review | |
| Larsen et al. | An RNA-based vaccine platform for use against Mycobacterium tuberculosis | |
| Tian et al. | Oral administration of Lactobacillus casei expressing flagellin A protein confers effective protection against Aeromonas veronii in common carp, Cyprinus carpio | |
| Rainard et al. | Progress towards the elusive mastitis vaccines | |
| Dow | Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) associated autoimmune diseases | |
| Lu et al. | Characterization of Treponema pallidum dissemination in C57BL/6 mice | |
| Bao et al. | A small protein but with diverse roles: a review of EsxA in mycobacterium–host interaction | |
| López-Roa et al. | Updated review on the mechanisms of pathogenicity in Mycobacterium abscessus, a rapidly growing emerging pathogen | |
| Arrigoni et al. | Antibiotic resistance to Mycobacterium tuberculosis and potential use of natural and biological products as alternative anti-mycobacterial agents | |
| Schütte et al. | Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer) | |
| Gnanagobal et al. | Host–pathogen interactions of marine gram-positive bacteria | |
| Rauf et al. | Humoral and cell-mediated immune response validation in calves after a live attenuated vaccine of Babesia bigemina | |
| Anes et al. | ESAT-6 a major virulence factor of Mycobacterium tuberculosis | |
| Téllez-Martínez et al. | A Recombinant enolase-Montanide™ PetGel a vaccine promotes a protective Th1 immune response against a highly virulent Sporothrix schenckii by toluene exposure |